Dxcover Ltd.

The Future of Cancer Diagnostics

Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company pioneered Multi-Omic Spectral Analysis for the early detection of cancer and validated the test in multiple solid tumor types including brain, colorectal, lung, pancreatic, ovarian, kidney and others.

Address

Glasgow
United Kingdom
Loading